Gossamer Bio Ownership | Who Owns Gossamer Bio?
Gossamer Bio Ownership Summary
Gossamer Bio is owned by 73.70% institutional investors, 3.29% insiders, and 23.01% retail investors. Octagon capital advisors lp is the largest institutional shareholder, holding 8.11% of GOSS shares. Fidelity Select Biotechnology is the top mutual fund, with 3.48% of its assets in Gossamer Bio shares.
GOSS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Gossamer Bio | 73.70% | 3.29% | 23.01% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Octagon capital advisors lp | 18.35M | 8.11% | $16.60M |
Nea management company | 18.09M | 7.99% | $16.37M |
Vanguard group | 10.03M | 4.43% | $9.08M |
Alyeska investment group | 8.81M | 3.89% | $7.97M |
Arch venture management | 8.06M | 3.56% | $7.29M |
Fmr | 7.93M | 3.50% | $7.18M |
683 capital management | 6.97M | 3.08% | $6.31M |
Palo alto investors lp | 6.28M | 2.77% | $5.68M |
Silverarc capital management | 6.17M | 2.73% | $5.58M |
Samsara biocapital | 6.13M | 2.71% | $5.55M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Arch venture management | 8.06M | 3.17% | $7.29M |
Octagon capital advisors lp | 18.35M | 2.73% | $16.60M |
Silverarc capital management | 6.17M | 1.22% | $5.58M |
Nea management company | 18.09M | 0.92% | $16.37M |
Palo alto investors lp | 6.28M | 0.88% | $5.68M |
Samsara biocapital | 6.13M | 0.76% | $5.55M |
Exome asset management | 1.10M | 0.75% | $993.25K |
Opaleye management | 4.49M | 0.71% | $4.06M |
Monaco asset management sam | 5.37M | 0.70% | $4.86M |
Allostery investments lp | 613.03K | 0.58% | $554.54K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Octagon capital advisors lp | 18.35M | 2.73% | 9.16M |
Alyeska investment group | 8.81M | 0.03% | 3.04M |
Monaco asset management sam | 5.37M | 0.70% | 1.52M |
683 capital management | 6.97M | 0.39% | 1.18M |
Acadian asset management | 5.10M | 0.01% | 1.16M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ecor1 capital | - | - | -9.20M |
Siren | 5.21M | 0.21% | -8.07M |
Price t rowe associates inc /md/ | 64.78K | - | -6.37M |
Farallon capital management | - | - | -6.13M |
Madison avenue partners, lp | - | - | -4.14M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Allostery investments lp | 613.03K | 0.58% | 613.03K | $554.54K |
Opti capital management, lp | 182.32K | 0.01% | 182.32K | $164.93K |
Merriman wealth management | 142.27K | 0.01% | 142.27K | $128.70K |
Jefferies financial group | 100.00K | 0.00% | 100.00K | $90.46K |
Velan capital investment management lp | 75.00K | 0.06% | 75.00K | $67.84K |
Sold Out
Holder | Change |
---|---|
Zurcher kantonalbank (zurich cantonalbank) | -4.00 |
Northwestern mutual wealth management | -261.00 |
Wells fargo & company/mn | -264.00 |
Global retirement partners | -300.00 |
Farther finance advisors | -400.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 108 | 0.93% | 166,819,185 | -4.61% | 73 | 1.23% | 46 | 4.55% | 24 | -11.11% |
Sep 30, 2024 | 107 | 7.00% | 174,874,925 | -4.36% | 77 | 1.18% | 44 | 7.32% | 27 | -10.00% |
Jun 30, 2024 | 100 | -11.50% | 182,850,856 | -7.56% | 81 | 1.05% | 41 | -21.15% | 30 | -3.23% |
Mar 31, 2024 | 113 | 10.78% | 197,807,122 | -5.44% | 87 | 1.02% | 52 | -5.45% | 31 | 47.62% |
Dec 31, 2023 | 102 | 4.08% | 209,181,540 | 2.23% | 92 | 0.82% | 55 | -12.70% | 21 | 16.67% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Select Biotechnology | 7.91M | 3.48% | - |
Vanguard US Total Market Shares ETF | 7.84M | 3.45% | - |
Vanguard Total Stock Mkt Idx Inv | 6.76M | 2.98% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 2.97M | 1.31% | 89.54K |
Fidelity Extended Market Index | 1.04M | 0.46% | -6.64K |
Schwab US Small-Cap ETF™ | 873.33K | 0.38% | 3.20K |
Federated Hermes Kaufmann Small Cap Grow | 766.28K | 0.34% | -3.07M |
Federated Hermes Kaufmann Small Cap A | 766.28K | 0.34% | -3.07M |
Vanguard Health Care ETF | 642.15K | 0.28% | -1.67K |
Victory Science & Technology | 571.93K | 0.25% | -6.11K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 24, 2024 | Aranda Richard | Chief Medical Officer | Sell | $1.26K |
Jun 21, 2024 | Hasnain Faheem | President & CEO | Buy | $250.28K |
Jun 18, 2024 | Giraudo Bryan | COO/CFO | Buy | $59.11K |
Jun 17, 2024 | Smith Robert Paul JR | Chief Commercial Officer | Buy | $15.05K |
Mar 27, 2024 | Christian Waage | EVP, Tech Ops and Admin | Sell | $7.43K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q2 | 3 | 1 |
2024 Q1 | - | 5 |
2023 Q4 | 2 | - |
2023 Q3 | - | - |
GOSS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools